Type 1 diabetes (T1D) results from an autoimmune-mediated destruction of pancreatic β cells. The incidence of T1D is on the rise globally around 3% to 5% per year and rapidly increasing incidence in younger children is of the greatest concern. currently, there is no way to cure or prevent T1D; hence, a deeper understanding of the underlying molecular mechanisms of this disease is essential to the development of new effective therapies. The endoplasmic reticulum (ER) is an organelle with multiple functions that are essential for cellular homeostasis. Excessive demand on the ER, chronic inflammation, and environmental factors lead to ER stress and to re-establish cellular homeostasis, the adaptive unfolded protein response (UPR) is triggered. However, chronic ER stress leads to a switch from a prosurvival to a proapoptotic UPR, resulting in cell death. Accumulating data have implicated ER stress and defective UPR in the pathogenesis of inflammatory and autoimmune diseases, and ER stress has been implicated in β-cell failure in type 2 diabetes. However, the role of ER stress and the UPR in β-cell pathophysiology and in the initiation and propagation of the autoimmune responses in T1D remains undefined. This review will highlight the current understanding and recent in vivo data on the role of ER stress and adaptive responses in T1D pathogenesis and the potential therapeutic aspect of enhancing β-cell ER function and restoring UPR defects as novel clinical strategies against this disease.
Get full access to this article
View all access options for this article.
References
1.
LehuenA, DianaJ, ZacconeP, . Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol2010;10:501–13.
2.
MathisD, VenceL, BenoistC. beta-Cell death during progression to diabetes. Nature2001;414:792–8.
3.
AtkinsonMA, EisenbarthGS, MichelsAW. Type 1 diabetes. Lancet2014;383:69–82.
4.
van BelleTL, CoppietersKT, von HerrathMG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev2011;91:79–118.
5.
DonathMY, StorlingJ, MaedlerK, . Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med (Beri)2003;81:455–70.
6.
OdegaardJI, ChawlaA. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harb Perspect Med2012;2:a007724.
7.
DonathMY. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov2014;13:465–76.
8.
ShoelsonSE, LeeJ, GoldfineAB. Inflammation and insulin resistance. J Clin Invest2006;116:1793–801.
9.
Brooks-WorrellB, NarlaR, PalmerJP. Islet autoimmunity in phenotypic type 2 diabetes patients. Diabetes Obes Metab2013;15(Suppl 3):137–40.
10.
ReinehrT. Type 2 diabetes mellitus in children and adolescents. World J Diabetes2013;4:270–81.
11.
ItariuBK, StulnigTM. Autoimmune aspects of type 2 diabetes mellitus - a mini-review. Gerontology2014;60:189–96.
12.
MingesKE, WhittemoreR, GreyM. Overweight and obesity in youth with type 1 diabetes. Annu Rev Nurs Res2013;31:47–69.
13.
HotamisligilGS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell2010;140:900–17.
14.
KarsM, YangL, GregorMF, . Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes2010;59:1899–905.
15.
OzcanU, CaoQ, YilmazE, . Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science2004;306:457–61.
16.
BernalesS, PapaFR, WalterP. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol2006;22:487–508.
17.
WalterP, RonD. The unfolded protein response: from stress pathway to homeostatic regulation. Science2011;334:1081–6.
18.
RonD, WalterP. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol2007;8:519–29.
19.
StørlingJ, BinzerJ, AnderssonAK, . Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia2005;48:2039–50.
20.
ChambersKT, UnverferthJA, WeberSM, . The role of nitric oxide and the unfolded protein response in cytokine-induced beta-cell death. Diabetes2008;57:124–32.
21.
OyadomariS, TakedaK, TakiguchiM, . Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway. Proc Natl Acad Sci USA2001;98:10845–50.
22.
OslowskiCM, HaraT, O'Sullivan-MurphyB, . Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab2012;16:265–73.
23.
LuB, NakamuraT, InouyeK, . Novel role of PKR in inflammasome activation and HMGB1 release. Nature2012;488:670–4.
24.
LernerAG, UptonJP, PraveenPV, . IRE1alpha induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab2012;16:250–64.
BlässS, UnionA, RaymackersJ, . The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum2001;44:761–71.
27.
ToddDJ, LeeAH, GlimcherLH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol2008;8:663–74.
28.
StøyJ, EdghillEL, FlanaganSE, . Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A2007;104:15040–4.
29.
WangJ, TakeuchiT, TanakaS, . A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. J Clin Invest1999;103:27–37.
30.
IzumiT, Yokota-HashimotoH, ZhaoS, . Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes2003;52:409–16.
31.
ColomboC, PorzioO, LiuM, . Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest2008;118:2148–56.
32.
MolvenA, RingdalM, NordbøAM, . Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes2008;57:1131–5.
33.
PolakM, DechaumeA, CavéH, . Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes2008;57:1115–9.
34.
ZhangP, McGrathB, LiS, . The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol2002;22:3864–74.
35.
HardingHP, ZhangY, BertolottiA, . Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell2000;5:897–904.
36.
DelépineM, NicolinoM, BarrettT, . EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet2000;25:406–9.
37.
OyadomariS, YunC, FisherEA, . Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload. Cell2006;126:727–39.
38.
ScheunerD, SongB, McEwenE, . Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell2001;7:1165–76.
39.
LadigesWC, KnoblaughSE, MortonJF, . Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK. Diabetes2005;54:1074–81.
40.
LipsonKL, FonsecaSG, IshigakiS, . Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. Cell Metab2006;4:245–54.
41.
SongB, ScheunerD, RonD, . Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest2008;118:3378–89.
42.
LeeAH, HeidtmanK, HotamisligilGS, . Dual and opposing roles of the unfolded protein response regulated by IRE1alpha and XBP1 in proinsulin processing and insulin secretion. Proc Natl Acad Sci USA2011;108:8885–90.
43.
FonsecaSG, IshigakiS, OslowskiCM, . Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest2010;120:744–55.
44.
TerseySA, NishikiY, TemplinAT, . Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes2012;61:818–27.
45.
MarhfourI, LopezXM, LefkaditisD, . Expression of endoplasmic reticulum stress markers in the islets of patients with type 1 diabetes. Diabetologia2012;55:2417–20.
46.
EnginF, YermalovichA, NguyenT, . Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes. Sci Transl Med2013;5:211ra156.
47.
EnginF, NguyenT, YermalovichA, . Aberrant islet unfolded protein response in type 2 diabetes. Sci Rep2014;4:4054.
48.
ErbayE, BabaevVR, MayersJR, . Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med2009;15:1383–91.
49.
OzcanU, YilmazE, OzcanL, . Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science2006;313:1137–40.
50.
EnginF, HotamisligilGS. Restoring endoplasmic reticulum function by chemical chaperones: an emerging therapeutic approach for metabolic diseases. Diabetes Obes Metab2010;12:108–15.
51.
BluestoneJA, HeroldK, EisenbarthG. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature2010;464:1293–300.
